Petrelintide is part of an emerging class of drugs that bind to and activate the amylin receptor. The once-weekly injectable Zealand drug is a peptide engineered to be a long-acting version of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback